Display options
Share it on

Neurochem Res. 1977 Oct;2(5):555-79. doi: 10.1007/BF00966015.

Carnosine in olfaction : Proton magnetic resonance spectral evidence for tissue-specific carnosine binding sites.

Neurochemical research

C E Brown, F L Margolis, T H Williams, R G Pitcher, G Elgar

Affiliations

  1. Roche Institute of Molecular Biology, 07110, Nutley, New Jersey.

PMID: 24272246 DOI: 10.1007/BF00966015

Abstract

The amount and specificity of binding ofL-carnosine (β-alanyl-L-histidine) by crude soluble and particulate fractions of several tissues were investigated with proton magnetic resonance ((1)HMR) spectrometry. It was found that the particulate fraction of only nasal olfactory mucosa exhibited a specific binding requiring a particular orientation of the carnosine molecule relative to the binding site. This suggests that whatever role carnosine may play in olfaction is expressed within the nasal olfactory mucosa rather than elsewhere in the olfactory pathway. Possible binding of carnosine to carnosinase was observed in the soluble fractions of nasal olfactory mucosa and kidney. However, the bulk of the carnosine present in the nasal olfactory mucosa in vivo probably is not bound within the cells of this tissue as a complex with soluble protein. These observations are of interest because the nasal olfactory mucosa is the neural tissue that has the highest activities of the enzymes catalyzing the synthesis and degradation of carnosine.The results of this investigation indicate that(1)HMR spectrometry will prove useful for the measurement of transmitter/receptor recognition. The significance of these results in the general context of measurement of "specific" binding interactions by biological samples is discussed, and a basic description of the application of(1)HMR spectrometry to these measurements is presented.

References

  1. Biochemistry. 1970 Nov 10;9(23):4555-66 - PubMed
  2. J Am Chem Soc. 1965 Mar 5;87:1065-70 - PubMed
  3. Adv Protein Chem. 1970;24:447-545 - PubMed
  4. Science. 1974 May 24;184(4139):909-11 - PubMed
  5. Mol Pharmacol. 1965 Nov;1(3):214-30 - PubMed
  6. Fed Proc. 1976 Jun;35(8):1924-30 - PubMed
  7. J Am Chem Soc. 1965 Jul 20;87:3237-44 - PubMed
  8. Brain Res. 1975 Aug 22;94(1):75-86 - PubMed
  9. Brain Res. 1974 Dec 13;81(3):469-83 - PubMed
  10. Brain Res. 1974 Nov 15;80(2):359-64 - PubMed
  11. Brain Res. 1976 Jul 9;110(2):351-60 - PubMed

Publication Types